With 32,080 new COVID-19 infections, India’s total cases rise to 97,35,850.
Reporting 402 new deaths, toll mounts to 1,41,360. Total active cases at 3,78,909.
Total discharged cases at 92,15,581 with 36,635 new discharges in the last 24 hours.
Maharashtra continues to report the maximum number of active cases in the country at 74,460 followed by Kerala with 59,873 active cases whereas Delhi has reported 22,310 active cases, 5,65,039 recoveries and 9,763 fatalities, according to the Union health ministry.
Jharkhand’s COVID-19 tally mounted to 1,10,639 as 182 more people tested positive for the virus, a health department official said on Wednesday. The COVID-19 death toll in the state remained at 988 as no new fatality due to the infection was reported in the last 24-hours, he said.
Mizoram reports 9 new COVID-19 cases, taking the total number of cases to 3977.
Active cases in the state is199, a total of 3772 patients have been already discharged with 6 Deaths.
Arunachal’s daily active cases of COVID-19 drops below 700 for the first time in last 5 months. Though health situation may seem to improve, still we can’t let our guards down.
5 new Covid-19 cases in Andamans, tally rises to 4,778. The Union Territory now has 70 active cases, while 61 people have so far died due to the infection. The Andaman and Nicobar administration has conducted 1,42,665 sample tests for Covid-19 so far.
Here’re some more information related to COVID-19:
*Maggie 90 years old women becomes first person in the world to receive a fully-tested and approved Covid-19 vaccine on the NHS.
*Drugmaker AstraZeneca’s coronavirus vaccine candidate is confirmed to have 70.4% efficacy and “a good safety profile” .
*Serum Institute of India, the world’s largest vaccine producer by volume, has sought emergency use authorization in the country for AstraZeneca Plc’s COVID-19 vaccine candidate, its chief executive officer said on Monday.
*The FDA’s vaccine advisory committee released a detailed analysis finding that Pfizer’s coronavirus vaccine appears to meet the safety and efficacy requirements necessary for an emergency use authorization.